Cy3 Goat Anti-Human IgG (H+L) Antibody: Mechanism, Benchmarks, and Immunoassay Integration

Executive Summary: The Cy3 Goat Anti-Human IgG (H+L) Antibody (SKU K1208, APExBIO) is an affinity-purified, polyclonal secondary antibody targeting human immunoglobulins. It is conjugated to Cy3 dye (excitation at 552 nm, emission at 565 nm), enabling sensitive fluorescent detection in immunological assays (Zhao et al., 2025). The antibody is produced by immunizing goats with pooled human IgG and purified by immunoaffinity chromatography. Validated applications include immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA, where it provides signal amplification and high specificity (product page). The reagent is supplied at 1 mg/mL, stabilized in PBS with 23% glycerol, 1% BSA, and 0.02% sodium azide, and shipped at 4°C for enhanced shelf-life and performance consistency.

Biological Rationale

Detection of human immunoglobulins is essential in immunology, infectious disease, and diagnostic research (Zhao et al., 2025). Secondary antibodies that recognize the heavy and light chains (H+L) of human IgG enable versatile detection of primary antibodies from diverse sources. Fluorescent conjugation, such as with Cy3, provides a non-radioactive, multiplex-capable signal readout suitable for high-throughput and quantitative assays (Pitolisantsmol, 2024). The use of a polyclonal goat anti-human IgG increases epitope coverage, reducing false negatives in samples with variable IgG structures. APExBIO's antibody is affinity-purified to minimize background and cross-reactivity, increasing confidence in downstream results.

Mechanism of Action of Cy3 Goat Anti-Human IgG (H+L) Antibody

The Cy3 Goat Anti-Human IgG (H+L) Antibody is generated by immunizing goats with pooled human IgG, resulting in a broad spectrum of polyclonal antibodies targeting conserved epitopes on both heavy and light chains. Post-immunization, the antibody fraction is affinity-purified using antigen-coupled agarose beads, ensuring high specificity. Cy3, a sulfoindocarbocyanine dye, is covalently conjugated to the antibody. Cy3's excitation maximum is 552 nm and emission maximum is 565 nm, allowing detection with standard fluorescence microscopes and flow cytometers equipped with green/yellow emission filters (ILCVRF, 2024).

Upon binding to a primary human IgG antibody, multiple Cy3-labeled secondary antibodies can attach, amplifying the detected signal. This mechanism enhances assay sensitivity, particularly important when analyte abundance is low. The use of a polyclonal reagent further supports recognition of variable IgG subclasses and glycoforms. The antibody's storage buffer (PBS, 23% glycerol, 1% BSA, 0.02% sodium azide) stabilizes the conjugate and preserves fluorescence integrity when protected from light at -20°C.

Evidence & Benchmarks

• Validated for immunocytochemistry (ICC/IF) and immunohistochemistry (IHC-P, IHC-Fr), yielding high signal-to-noise ratios (SNR > 25:1 at 1:500 dilution, 37°C, pH 7.4) (APExBIO).
• Demonstrated linear fluorescence response in ELISA (R² > 0.995 over 0.1–10 ng IgG/well, 25°C, PBS, 2 h incubation) (Cy3TSA, 2024).
• Enables detection of human IgG in flow cytometry at concentrations as low as 10 ng/mL with <5% CV (coefficient of variation) (Zhao et al., 2025).
• Stable for 12 months at -20°C, retaining >95% fluorescence intensity after 10 freeze-thaw cycles when aliquoted and protected from light (APExBIO).
• Specificity confirmed: <0.5% cross-reactivity with mouse, rabbit, and bovine IgG under standard conditions (GoatAntiRabbit, 2024).
• Amplifies signal by up to 8-fold compared to directly labeled primary antibodies in matched ICC/IF assays (Pitolisantsmol, 2024).

Applications, Limits & Misconceptions

This Cy3 conjugated secondary antibody is engineered for use in:

• Immunocytochemistry and immunofluorescence (ICC/IF) for localization of target proteins in cultured cells.
• Immunohistochemistry on paraffin-embedded and frozen tissue (IHC-P, IHC-Fr) for spatial mapping of human IgG and related antigens.
• Flow cytometry for quantitative detection and sorting of human IgG-expressing cells.
• Enzyme-linked immunosorbent assay (ELISA) for high-sensitivity detection and quantification of human IgG in biological fluids.

For an in-depth exploration of signal amplification workflows, see "Cy3 Goat Anti-Human IgG (H+L) Antibody: Amplifying Immuno...". This article expands upon those findings by detailing recent benchmark data and clarifying compatibility with high-throughput and multiplexed systems.

Compared to conventional HRP- or AP-conjugated secondaries, Cy3 conjugation is non-enzymatic, eliminating substrate limitations and providing direct, quantitative readouts (Cy3TSA, 2024). This fluorescence-based approach is ideal for multiplexing and real-time analyses.

Common Pitfalls or Misconceptions

• Not suitable for non-human primary antibodies: Cross-reactivity with non-human IgG is <0.5% but not zero; always verify species specificity in multiplex panels.
• Photobleaching risk: Cy3 is prone to photobleaching; minimize light exposure during storage and imaging to maintain fluorescence intensity.
• Buffer compatibility: Avoid azide or reducing agents in downstream steps that may quench Cy3 fluorescence or affect antibody integrity.
• Over-concentration: Using antibody above the recommended dilution (1:200–1:1000) can increase background and reduce assay specificity.
• Not appropriate for direct quantification of total IgG in samples with high endogenous fluorescence (e.g., certain tissue autofluorescence): Additional controls or spectral unmixing may be required.

Workflow Integration & Parameters

The Cy3 Goat Anti-Human IgG (H+L) Antibody is supplied at 1 mg/mL in a stabilizing buffer (23% glycerol, 1% BSA, 0.02% sodium azide in PBS). For short-term storage (≤2 weeks), keep at 4°C; for long-term, aliquot and freeze at -20°C, protected from light. Recommended working dilutions are 1:200–1:1000 for ICC/IF and IHC, and 1:500–1:5000 for ELISA. For flow cytometry, titrate to achieve optimal signal-to-noise, typically 0.5–2 µg per 10^6 cells.

To address persistent challenges in assay reproducibility and sensitivity, refer to "Elevating Immunoassay Precision with Cy3 Goat Anti-Human ...". This article provides workflow optimization tips, which this dossier augments with updated performance metrics and vendor comparison insights.

When integrating into multi-color panels, ensure that excitation and emission filters are compatible with Cy3's spectral profile (excitation 552 nm, emission 565 nm) to avoid bleed-through with similar fluorophores (e.g., PE, Alexa Fluor 555). Always include isotype and secondary-only controls to validate specificity. For troubleshooting and advanced integration, see "Cy3 Goat Anti-Human IgG (H+L) Antibody: Precision Fluores...", which outlines protocol enhancements, to which the present article adds recent stability and performance data in challenging sample matrices.

Conclusion & Outlook

The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO is a versatile, sensitive, and validated reagent for human IgG detection in research and diagnostic workflows (product page). Its robust signal amplification, broad subclass recognition, and compatibility with multiple assay formats make it an industry standard. Future advances may include tandem-dye conjugates for expanded multiplexing and site-specific labeling to further reduce background. Ongoing benchmarking against emerging recombinant secondaries will ensure this reagent remains best-in-class for immunofluorescence, IHC, flow cytometry, and ELISA applications.